Anzeige
Mehr »
Sonntag, 28.06.2026 - Börsentäglich über 12.000 News
Brasiliens Moment für seltene Erden ist gekommen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Marketwired
38 Leser
Artikel bewerten:
(0)

Government of Canada Announces New Steps to Help the Medical Community with Marijuana for Medical Purposes

OTTAWA, ONTARIO -- (Marketwired) -- 03/31/14 -- Health Canada

Marijuana is not an approved drug or medicine in Canada and has not gone through the necessary rigorous scientific trials for efficacy or safety.

Health Canada does not endorse the use of marijuana, but the courts have required reasonable access to a legal source of marijuana for medical purposes.

As a result, the Government of Canada believes that this must be done in a controlled fashion to protect public health and safety.

Over the last several months, Minister Ambrose has been reaching out to the medical community to work together to address common concerns around the use of marijuana as a treatment, including the lack of dosage guidelines and appropriate health cautions. Health Canada is working with provincial and territorial medical and nursing licensing bodies to increase the information provided to them on how doctors and nurse practitioners are authorizing marijuana and in what quantities.

In addition, Minister Ambrose has directed Health Canada to work with secure commercial operators licensed to produce marijuana to enhance information-sharing with regulatory oversight bodies

on how doctors and nurse practitioners are authorizing the use of marijuana.

Furthermore, Minister Ambrose has also asked Health Canada to work with the medical and scientific community, to produce an additional informational document on marijuana for medical purposes to help support doctors and nurse practitioners in making decisions.

We expect these new measures, including information on dosage guidelines, educational material and increased oversight, will decrease the potential for over prescribing and negative health impacts.

Quick Facts

--  Marijuana is not an approved drug or medicine in Canada.

--  The Marihuana Medical Access Program, introduced in 2001, went from a
    few hundred people to almost 40,000 which created consequences for
    public health, safety and security, as a result of allowing individuals
    to produce marijuana in their homes.

--  We heard from local mayors, fire chiefs, police officers and community
    members that there were serious health and safety concerns about the old
    program.

--  The medical community has asked the Government to work with them and
    share information.

--  There are potentially serious harmful effects from using marijuana
    beginning at a young age and it should not be promoted.

--  Youth are especially susceptible to the negative effects of marijuana
    use, including harmful effects on mental functioning and mental health
    including psychosis and schizophrenia.

Quotes

"I want to emphasize that marijuana is not an approved drug or medicine in Canada. Health Canada does not endorse the use of marijuana, but the courts have required reasonable access to a legal source of marijuana for medical purposes."

Rona Ambrose, Minister of Health

"I continue to hear concerns from health professional organizations that dried marijuana is not an approved drug or medicine in Canada. They want clearer guidance on safety and effectiveness and want authorizations to be monitored. That is why I asked Health Canada to consult with provincial and territorial regulatory bodies, companies licensed to produce marijuana and other professional organizations to enhance information-sharing on how doctors and nurse practitioners are authorizing the use of marijuana."

Rona Ambrose, Minister of Health

"Medical regulatory authorities have serious concerns about prescribing a product like marijuana that is not an approved drug. Since marijuana can nevertheless be prescribed, it should be done in a way that allows us to exercise our duty to act in the public interest. We are encouraged by the direction given to Health Canada that licensed producers will share information about physician prescribers with us so it can be reviewed for quality assurance and complaint processes."

Rocco Gerace, MD, President, Federation of Medical Regulatory Authorities of Canada

"As public health advocates, we stress the importance of making clear to the public and to policy makers that marijuana is not a harmless drug, but an increasingly potent and addictive one that can harm school and work performance, brain maturation in the fetus and the adolescent, mental health, driving skills, and can cause physical harm to the respiratory system and various other organs."

Dr. Harold Kalant, Smart Approaches to Marijuana Canada

Health Canada news releases are available on the Internet at: www.healthcanada.gc.ca/media.

Contacts:
Michael Bolkenius
Office of the Honourable Rona Ambrose
Federal Minister of Health
(613) 957-0200

Health Canada
Media Relations
(613) 957-2983

Public Inquiries:
(613) 957-2991
1-866 225-0709

© 2014 Marketwired
SpaceX-Hype zu teuer – Diese 5 Aktien bieten bessere Chancen
Raumfahrt-Aktien gehören aktuell zu den heißesten Wetten an den Börsen. Spätestens mit dem spektakulären Börsengang von SpaceX ist der Sektor endgültig im Fokus der Anleger angekommen. Fantasien rund um Satellitenkommunikation, Rechenzentren im All und neue Geschäftsmodelle treiben die Kurse immer weiter nach oben.

Doch während die Begeisterung steigt, werden auch die Risiken größer. Viele Space-Start-ups sind inzwischen extrem hoch bewertet, arbeiten noch nicht profitabel und hängen stark von stetigem Kapitalzufluss ab. Schon kleine Rückschläge könnten die ambitionierten Wachstumspläne ins Wanken bringen.

Für Anleger, die vom Boom der Raumfahrt profitieren wollen, lohnt sich daher ein Perspektivwechsel. Statt auf überhitzte Pure Plays zu setzen, rücken etablierte Konzerne in den Fokus – Unternehmen mit jahrzehntelanger Erfahrung, stabilen Cashflows und engen Verbindungen zu Raumfahrtagenturen wie NASA und ESA.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau dieses Profil erfüllen: solide bewertet, operativ stark und bestens positioniert, um langfristig vom Space-Boom zu profitieren.

Jetzt den kostenlosen Report sichern – bevor der Markt die versteckten Gewinner entdeckt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.